Literature DB >> 30805835

7-Chloro-4-(Phenylselanyl) Quinoline with Memory Enhancer Action in Aging Rats: Modulation of Neuroplasticity, Acetylcholinesterase Activity, and Cholesterol Levels.

Anelise Barth1, Ane G Vogt1, Angélica S Dos Reis1, Mikaela P Pinz1, Roberta Krüger2, William B Domingues3, Diego Alves2, Vinicius F Campos3, Simone Pinton4, Natália Paroul5, Ethel A Wilhelm6,7, Cristiane Luchese8,9.   

Abstract

This study investigated the effect of 7-chloro-4-(phenylselanyl) quinoline (4-PSQ) to restore the cognitive impairment caused by aging in male Wistar rats. Moreover, modulation of neuroplasticity markers, acetylcholinesterase (AChE) activity, and cholesterol levels was performed. Aged rats were intragastrically treated with 4-PSQ (5 mg/kg) for 7 days. Animals were tested in behavioral tasks, and then plasma (to determine cholesterol levels), hippocampus, and cerebral cortex (to determine neural cell adhesion molecule (NCAM) and polysialyltransferase (PST) levels, and AChE activity) were removed. Our findings demonstrated that treatment of aged rats with 4-PSQ restored short-term and long-term memories in the object recognition tests. 4-PSQ treatment did not restore exploratory activity (rearings) but partially restored locomotor activity (crossings) reduced by aging in the open-field test. Moreover, the compound restored the reduction in the NCAM and PST levels, and AChE activity in cerebral structures, as well as the increase in the plasma cholesterol levels, caused by aging in rats. In conclusion, 4-PSQ restored cognitive impairment caused by aging in rats by modulating synaptic plasticity, cholinergic system, and cholesterol levels.

Entities:  

Keywords:  Aging; Learning; Memory; Plasticity; Quinoline; Selenium

Mesh:

Substances:

Year:  2019        PMID: 30805835     DOI: 10.1007/s12035-019-1530-5

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  4 in total

1.  The neurotherapeutic role of a selenium-functionalized quinoline in hypothalamic obese rats.

Authors:  Ethel Antunes Wilhelm; Cristiane Luchese; Karline C Rodrigues; Cristiani F Bortolatto; Ketlyn P da Motta; Renata L de Oliveira; Jaini J Paltian; Roberta Krüger; Silvane S Roman; Silvana P Boeira; Diego Alves
Journal:  Psychopharmacology (Berl)       Date:  2021-03-19       Impact factor: 4.530

2.  Interface of Aging and Acute Peripheral Neuropathy Induced by Oxaliplatin in Mice: Target-Directed Approaches for Na+, K+-ATPase, Oxidative Stress, and 7-Chloro-4-(phenylselanyl) quinoline Therapy.

Authors:  Angélica S Reis; Carolina C Martins; Ketlyn P da Motta; Jaini J Paltian; Gabriel P Costa; Diego Alves; Cristiane Luchese; Ethel Antunes Wilhelm
Journal:  Mol Neurobiol       Date:  2022-01-13       Impact factor: 5.590

3.  7-Chloro-4-(Phenylselanyl) Quinoline Is a Novel Multitarget Therapy to Combat Peripheral Neuropathy and Comorbidities Induced by Paclitaxel in Mice.

Authors:  Jaini J Paltian; Angélica S Dos Reis; Amanda W S Martins; Eduardo B Blödorn; Eduardo N Dellagostin; Liane K Soares; Ricardo F Schumacher; Vinícius F Campos; Diego Alves; Cristiane Luchese; Ethel Antunes Wilhelm
Journal:  Mol Neurobiol       Date:  2022-08-15       Impact factor: 5.682

4.  Prospecting for a quinoline containing selenium for comorbidities depression and memory impairment induced by restriction stress in mice.

Authors:  Renata L de Oliveira; Guilherme T Voss; Karline da C Rodrigues; Mikaela P Pinz; Julia V Biondi; Nicole P Becker; Eduardo Blodorn; William B Domingues; Allya Larroza; Vinícius F Campos; Diego Alves; Ethel A Wilhelm; Cristiane Luchese
Journal:  Psychopharmacology (Berl)       Date:  2022-01-11       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.